Preterm Birth Diagnostic Test Kit Market to Experience Significant Growth to Reach USD 316.5 Million by 2034 with 7.6% of CAGR

Preterm Birth Diagnostic Test Kits Market
Preterm Birth Diagnostic Test Kits Market

The preterm birth diagnostic test kit market is set for substantial growth over the next decade. Valued at USD 152.2 million in 2024, the market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 7.6%, reaching an estimated USD 316.5 million by 2034.

The increasing prevalence of preterm births worldwide is a primary driver of this market’s growth. Early diagnosis and timely intervention are critical in managing preterm births, leading to a heightened demand for reliable and effective diagnostic test kits. These kits play a vital role in identifying the risk of preterm labor, enabling healthcare providers to take preventive measures and improve neonatal outcomes.

Advancements in diagnostic technologies and increased awareness about the importance of early detection are further fueling market expansion. The rising investment in research and development activities and the growing adoption of these test kits in healthcare facilities globally also contribute to the market’s positive outlook.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7551

One of the main factors propelling the market’s expansion is the increased public awareness of preterm birth difficulties and the need of early detection and intervention. It is projected that as healthcare systems around the world prioritize the health of women and infants and close critical gaps in prenatal care, the usage of preterm birth diagnostic test kits will increase dramatically.

The positive outlook for the worldwide market for preterm birth diagnostic test kits emphasizes how important it is for industry participants to keep coming up with new ideas, staying informed, and cooperating. As the industry grows, manufacturers, policymakers, and healthcare professionals will have a great chance to enhance prenatal care and reduce the number of premature births.

Key Findings Presented in the Report on the Preterm Birth Diagnostic Test Kits Market:

According to the data, the number of births in 2017 was roughly 115.4 million, of which 12.8 million or 11.1% were preterm. Preterm birth problems are the biggest cause of death for children under the age of five, according to the World Health Organization. In 2015, they were directly responsible for around one million deaths. Of these, cost-effective measures can avoid three-quarters of these deaths. Across different regions, preterm birth diagnostic test kit adoption rates varied from 2% to 15%. A substantial chunk of the preterm birth test kit market has gone untapped, leaving it open for manufacturers of preterm diagnostic test kits. This is because the majority of the current patient pool is ignorant of the cost-saving advantages of preterm birth diagnostic test kits.

Analysis of the Preterm Birth Diagnostic Test Kits Market:

The most common sample used for preterm labor and premature membrane rupture diagnosis in preterm birth diagnostic test kits is blood. The most popular and widely recognized preterm birth diagnostic test kits among end users are those that employ blood samples for preterm birth diagnosis. On the other hand, preterm birth diagnostic test kits using vaginal discharge sample type are becoming more and more common.

Patients experiencing symptoms of preterm birth are primarily referred to hospitals, outpatient clinics, and diagnostic laboratories that use preterm birth diagnostic tests. Because they are the principal healthcare institution for preterm cases, hospitals are expected to account for the majority of the revenue share under the end users segment for the preterm birth diagnostic test kits market in 2017.

Preterm Birth Diagnostic Test Kits Market – Competitive Landscape:

The key players of this market are adopting strategies such as product launch, acquisition, partnership and collaborations to gain expand their market presence and open up new streams of revenue generation.

  • In June 2021, Medix Biochemica announced the launch of a new molecular diagnostic reagents division named “MedixMDx” to offer extensive range of products and services for their customers.
  • In September 2020, QIAGEN announced the acquisition of NeuMoDx Molecular Inc., which helped the company to complete their product portfolio of PCR technology based automated molecular testing solutions.
  • In May 2021, Sera Prognostics announced a strategic commercial partnership with Anthem Inc., to make their “PreTRM® “tests available to all the customers of Anthem in the U.S.

Since the awareness of preterm birth diagnostic test kits is increasing, the demand for these kits will rise in the next few years. This creates many lucrative opportunities for the key players of this industry.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-7551

Key Companies Profiled:

  • Qiagen
  • Medix Biochemica
  • Hologic Inc.
  • Sera Prognostics
  • IQ Products
  • Creative Diagnostics
  • Nanjing Liming Biological Preparations Co., Ltd.
  • Clinical Innovations, LLC
  • Bioserv Diagnostic GmbH

Preterm Birth Diagnostic Test Kits Market, By Category:

Product:

  • ffN Test
  • PAMG-1 Test
  • IGFBP-1 Test

Sample:

  • Blood
  • Urine
  • Vaginal Discharge

End User:

  • Hospitals
  • Diagnostic Laboratories
  • Outpatient Clinics
  • Research Centers

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Middle-East & Africa
  • APECJ
  • China
  • Japan

Secure Your Market Analysis Now: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/7551

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these